Comparative effectiveness of mood stabiliser monotherapy versus second-generation antipsychotic monotherapy versus combination therapy for continuation and maintenance treatment after a first episode of psychotic mania in North America, Chile, and Spain: a target trial emulation using data from the BD-CAUSAL Collaboration.
The lancet. Psychiatry · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
Come citare questo studio
Alejandro G Szmulewicz, Yu-Hsin Liang, Gonzalo Martínez-Alés, Ryan O'Dea, Lorna E Thorpe, Sarah Conderino, José M Rubio, Kerry Smith, Deepak K Sarpal, Covadonga M Díaz-Caneja, Celso Arango, Paul A Vöhringer, Sophia A Aldunate, Ridha Joober, Jai L Shah, Ashok Malla, Diane Fredrikson, Lakshmi N Yatham, Miguel A Hernán, Dost Öngür, BD-CAUSAL Collaboration. (2026). Comparative effectiveness of mood stabiliser monotherapy versus second-generation antipsychotic monotherapy versus combination therapy for continuation and maintenance treatment after a first episode of psychotic mania in North America, Chile, and Spain: a target trial emulation using data from the BD-CAUSAL Collaboration.. The lancet. Psychiatry. DOI: 10.1016/s2215-0366(26)00239-7
Consulta la pubblicazione originale ↗